Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

This study has been completed.
Information provided by:
Mylan Pharmaceuticals Identifier:
First received: March 28, 2008
Last updated: March 31, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)